Skip to main content

2 Result(s)

within N Quénel Remove this filter Biomedicine Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients

    Tamoxifen as sole initial therapy is gaining importance in the management of post-menopausal breast cancer patients. Age oestrogen (ER) and progesterone (PR) receptor status are accurately considered to select...

    I Soubeyran, N Quénel, J-M Coindre, F Bonichon, M Durand… in British Journal of Cancer (1996)

  2. No Access

    Article

    Variation of hormonal receptor, pS2, c-erbB-2 and GSTπ contents in breast carcinomas under tamoxifen: a study of 74 cases

    Seventy-four post menopausal patients with primary non-metastatic invasive ductal carcinomas of the breast were first treated with tamoxifen alone (30 mg p.o. daily) for 5 months. To study changes induced by t...

    I Soubeyran, N Quénel, L Mauriac, M Durand, F Bonichon… in British Journal of Cancer (1996)